Skip to main content

Press Kit

Official resources and media assets for coverage of SmartCemic QESA Pro and NorCemic Inc.

Key Facts & Figures

114+
Biomarkers
±5%
Accuracy
<2s
Results
2022
Founded

About NorCemic Inc.

Company Overview

NorCemic Inc. is a pioneering medical technology company headquartered in Phoenix, Arizona, focused on non-invasive health monitoring. Our flagship product, SmartCemic QESA Pro, uses proprietary quantum-enhanced spectral analysis (QESA) technology to provide real-time monitoring of 114+ biomarkers without the need for blood draws or invasive procedures. The company was founded in 2022 with a mission to democratize comprehensive health monitoring.

Mission Statement

To revolutionize personal health monitoring by making comprehensive biomarker analysis accessible, painless, and continuous for everyone—empowering individuals to take proactive control of their health journey through cutting-edge quantum technology.

Technology

SmartCemic QESA Pro combines Mid-Infrared (MIR) spectroscopy with Quantum Cascade Laser (QCL) technology, enhanced by advanced machine learning algorithms. This multi-spectral fusion approach enables clinical-grade accuracy in a compact, consumer-friendly device that delivers results in under 2 seconds.

Brand Assets

Logo Package

PNG, SVG, EPS formats in various sizes

Brand Guidelines

Colors, typography, usage rules

Product Photos

High-resolution product images

Fact Sheet

Key facts, specs, and figures

Press Releases

December 2024

SmartCemic QESA Pro Launch Announcement

NorCemic Inc. announces the commercial availability of SmartCemic QESA Pro, the world's first quantum-enhanced spectral analysis device for non-invasive health monitoring. The revolutionary device enables real-time monitoring of over 114 biomarkers including glucose, ketones, hydration levels, and comprehensive metabolic panels—all without needles or blood draws.

October 2024

SmartCemic QESA Pro Wellness Platform Launched

NorCemic Inc. launches SmartCemic QESA Pro wellness platform, bringing quantum-enhanced health monitoring technology to fitness enthusiasts and health-conscious consumers.

June 2024

US Patent Application Filed for QESA Technology

NorCemic Inc. files US patent application for its proprietary Quantum-Enhanced Spectral Analysis (QESA) technology, protecting key innovations in non-invasive biomarker detection.

Media Inquiries

For press inquiries, interviews, product reviews, or additional information, please contact our media relations team:

SmartCemic
SmartCemic Support
Online